Staffing costs typically consume 35–50% of medspa operating expenses, making compensation strategy central to profitability and retention. The market for qualified injectors and aestheticians has tightened significantly since 2022, driven by the explosive growth of aesthetic demand, the rise of MSO-backed chains competing for talent, and a shrinking pool of RNs willing to specialize in injectables. Understanding where salaries sit by geography, role, and experience—and what's moving the needle on compensation—is essential for budgeting, hiring, and staying competitive without eroding margins.